CLOSE X

BETA DRUGS LTD.

NSE : BETABSE : ISIN CODE : INE351Y01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE1605.50-37.4 (-2.28 %)
PREV CLOSE( ) 1642.90
OPEN PRICE ( ) 1651.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2044
TODAY'S LOW / HIGH( ) 1595.00 1665.30
52 WK LOW / HIGH ( )1429.52 2105.67
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 21-09 2005
Management Info
Rahul Batra - Chairman Rahul Batra - Managing Director
Registered Office

Address Village Nandpur,Lodhimajra Road,Distt Solan,
Baddi,
Himachal Pradesh-174101

Phone 01795-236196

Email cs@betadrugslimited.com

Website www.betadrugslimited.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : NSE
NEWS
16Oct Updates
Beta Drugs Limited has informed the Exchange regarding 'BETA DRUGS LIMIT..
13Oct General Announcement
Beta Drugs Limited has informed the Exchange about Certificate under SEB..
30Sep Outcome of AGM
Beta Drugs Limited has informed the Exchange regarding Proceedings of An..
30Sep Closure of Trading Window
Beta Drugs Limited has informed the Exchange regarding the Trading Windo..
22Sep Updates
Beta Drugs Limited has informed the Exchange regarding 'Beta Drugs Limit..
Financials
in Millions
QTR ANNUAL 25
Net Profit154.31
Gross Profit 208.39
Operating Profit 376.07
Net Sales 2202
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
CORONA Remedies (BSE)
up  1437.20 (35.33%)
M.Cap ( in Cr)8789.93
Neuland Laboratories (BSE)
up  16421.90 (2.15%)
M.Cap ( in Cr)21069.12
Procter&Gamble Healt (BSE)
up  5675.85 (1.74%)
M.Cap ( in Cr)9421.56
Fredun Pharma (BSE)
up  1660.40 (5.00%)
M.Cap ( in Cr)783.98
RPG Life Sciences (BSE)
up  2372.25 (2.78%)
M.Cap ( in Cr)3923.47
Shareholding Pattern
PROMOTERS 66.73%
NON-INSTITUTION 32.08%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors